An optimized synthetic route to 7-deaza-8-bromo-cyclic adenosine 5'-diphosphate ribose (7-deaza-8-bromo-cADPR
3), an established cell-permeant, hydrolysis-resistant cyclic adenosine 5'-diphosphate ribose(cADPR) antagonist, is presented. Using NMR analysis, we found that
3 adopted a C-2' endo conformationin the N9-linked ribose and a syn conformation about the N9-glycosyl linkage, which are similar to thatof cADPR. The synthetic route was also employed to produce 7-deaza-2'-deoxy-cADPR
4, a potentialcell-permeant cADPR analogue.
3 and
4 were more stable to chemical hydrolysis, consistent with theobservation that 7-deaza-cADPR analogues are more stable than their parent adenosine derivatives.
3was also found to be stable to enzyme-mediated hydrolysis using CD38 ectoenzyme.